Literature DB >> 803467

Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies.

E Norrby, Y Gollmar.   

Abstract

The occurrence of antibodies giving hemolysis inhibition (HLI) but not hemagglutination inhibition (HI) was examined in human convalescent and rabbit hyperimmune sera. HI antibodies, which through their interaction with hemagglutinin components display HLI activity, were removed by absorption with Tween 80-ether (TE)-treated measles virus material. This absorption did not change the titer of non-HI HLI antibodies. After removal of HI antibodies from 16 late measles convalescent sera and three batches of gamma globulin. HLI antibody titers showed a two- to eightfold reduction. The titers of neutralizing antibodies were reduced from 1/4 to 1/20 of the original titers. There was a good correlation between the titers of neutralizing and HLI antibodies both in sera from which HI antibodies had been removed by absorption and in sera spontaneously showing markedly higher HLI than HI antibody titers. HLI antibodies with these characteristics could be identified in HI tests when whole virus instead of TE-treated material was used an antigen and anti-antiserum was added to the tests. In contrast to the situation in human sera, antibodies remaining after removal of HI antibodies from rabbit hyperimmune sera against purified virus particles were detectable in neutralization and HLI tests only in the presence of anti-antiserum. However, virus particles from which the major fraction of all envelope projections had been removed by treatment with 0.004% trypsin induced the production of non-HI HLI antibodies active also in the absence of anti-antiserum. TE and formalin treatment destroyed the hemolytic activity of virus preparations and also their capacity to induce a production of non-HI HLI antibodies.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803467      PMCID: PMC415050          DOI: 10.1128/iai.11.2.231-239.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.

Authors:  E NORRBY; R LAGERCRANTZ; S GARD
Journal:  Br Med J       Date:  1965-03-27

2.  Hemagglutination by measles virus. II. Properties of the hemagglutinin and of the receptors on the erythrocytes.

Authors:  E NORRBY
Journal:  Arch Gesamte Virusforsch       Date:  1962

3.  "Giant-cell" and "strand-forming" cytopathic effect of measles virus lines conditioned by serial propagation with diluted or concentrated inoculum.

Authors:  F G ODDO; R FLACCOMIO; A SINATRA
Journal:  Virology       Date:  1961-04       Impact factor: 3.616

4.  The effect of a carbobenzoxy tripeptide on the biological activities of measles virus.

Authors:  E Norrby
Journal:  Virology       Date:  1971-06       Impact factor: 3.616

5.  The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion.

Authors:  H D Klenk; L A Caliguiri; P W Choppin
Journal:  Virology       Date:  1970-10       Impact factor: 3.616

6.  Neurminidase associated with measles virus.

Authors:  C Howe; A Schluederberg
Journal:  Biochem Biophys Res Commun       Date:  1970-08-11       Impact factor: 3.575

7.  Presence of 2 different viral agents in brain cells of patients with subacute sclerosing panencephalitis.

Authors:  G Barbanti-Brodano; S Oyanagi; M Katz; H Koprowski
Journal:  Proc Soc Exp Biol Med       Date:  1970-05

8.  Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein.

Authors:  A Scheid; L A Caliguiri; R W Compans; P W Choppin
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

9.  Measles vaccination. 3. Serologic responses to immunization with purified hemagglutinin.

Authors:  E Norrby; R Lagercrantz; S Gard; G Carlström
Journal:  Acta Paediatr Scand       Date:  1965-11

10.  Flocculation of influenza virus by specific anti-neuraminidase antibody.

Authors:  A P Kendal; C R Madeley
Journal:  Arch Gesamte Virusforsch       Date:  1970
View more
  44 in total

1.  Purification of measles virus and characterization of subviral components.

Authors:  K C Stallcup; S L Wechsler; B N Fields
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

2.  Exposure to acidic pH causes irreversible conformational changes in the measles virus hemagglutinin.

Authors:  H Sheshberadaran
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Implication of vaccination on measles reduction and elimination in Nigeria.

Authors:  A B Onoja; K M Hamid; J A Adeniji; M D Mukhtar
Journal:  Afr J Med Med Sci       Date:  2014-09

4.  Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

Authors:  E Malvoisin; F Wild
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Monoclonal antibodies against five structural components of measles virus. II. Characterization of five cell lines persistently infected with measles virus.

Authors:  H Sheshberadaran; E Norrby; K W Rammohan
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

6.  Immunity after infections with Myxoviruses.

Authors:  M Majer
Journal:  Infection       Date:  1976       Impact factor: 3.553

7.  Glycoproteins of measles virus under reducing and nonreducing conditions.

Authors:  J M Hardwick; R H Bussell
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

8.  Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells.

Authors:  E Norrby; S N Chen; T Togashi; H Shesberadaran; K P Johnson
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

9.  Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus.

Authors:  E Norrby; M J Appel
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

10.  Separation of Sendai virus glycoproteins by using glutaraldehyde-treated erythrocytes and preparation of monospecific antisera against the glycoproteins.

Authors:  Y Hosaka
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.